190 related articles for article (PubMed ID: 34811734)
21. Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.
Borgatti A; Winter AL; Stuebner K; Scott R; Ober CP; Anderson KL; Feeney DA; Vallera DA; Koopmeiners JS; Modiano JF; Froelich J
PLoS One; 2017; 12(2):e0172651. PubMed ID: 28222142
[TBL] [Abstract][Full Text] [Related]
22. Flourine-18 fluorodeoxyglucose positron emission tomography imaging exhibits increased SUVmax at the level of the spinal intumescence in normal dogs.
French JM; Brody A; von Stade D; Frank CB; Griffin LR
Vet Radiol Ultrasound; 2020 May; 61(3):364-369. PubMed ID: 31916651
[TBL] [Abstract][Full Text] [Related]
23. Tumor Heterogeneity Detected by 68Ga DOTATOC and 18F-FDG PET/CTs in One Malignant Insulinoma With Involvement of the Portal Splenic Confluence and Ovarian Metastases.
Bélissant Benesty O; Cassou-Mounat T; Vatier C; Talbot JN; Montravers F
Clin Nucl Med; 2016 Nov; 41(11):874-876. PubMed ID: 27607168
[TBL] [Abstract][Full Text] [Related]
24. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
25. Comparison of ultrasonography, computed tomography, and single-photon emission computed tomography for the detection and localization of canine insulinoma.
Robben JH; Pollak YW; Kirpensteijn J; Boroffka SA; van den Ingh TS; Teske E; Voorhout G
J Vet Intern Med; 2005; 19(1):15-22. PubMed ID: 15715042
[TBL] [Abstract][Full Text] [Related]
26.
Sakaki K; Murakami T; Fujimoto H; Shimizu Y; Miyake KK; Otani D; Kiyobayashi S; Okada T; Fujimoto M; Hakata T; Yamauchi I; Shimada K; Shimizu H; Nagai K; Nakamoto Y; Inagaki N
Front Endocrinol (Lausanne); 2023; 14():1245573. PubMed ID: 37720533
[TBL] [Abstract][Full Text] [Related]
27. The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer.
Kim MJ; Lee KH; Lee KT; Lee JK; Ku BH; Oh CR; Heo JS; Choi SH; Choi DW
Pancreas; 2012 Aug; 41(6):897-903. PubMed ID: 22699202
[TBL] [Abstract][Full Text] [Related]
28. Positron emission tomography and computed tomography with [
Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
[TBL] [Abstract][Full Text] [Related]
29. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
30. The relation between staging fluorine-18 fluorodeoxyglucose positron emission tomog- raphy/computed tomography metabolic parameters and tumor necrosis rate in pediatric osteosarcoma patients.
Fidan AK; Uçmak G; Demirel BB; Efetürk H; Öztürk İ; Demirtaş Şenlik S; Esen Akkaş B; Ergürhan İlhan İ
Turk J Med Sci; 2021 Jun; 51(3):1115-1122. PubMed ID: 33387988
[TBL] [Abstract][Full Text] [Related]
31. The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose (
Lung MS; Hicks RJ; Pavlakis N; Link E; Jefford M; Thomson B; Wyld DK; Liauw W; Akhurst T; Kuru N; Michael M
Asia Pac J Clin Oncol; 2020 Jun; 16(3):150-157. PubMed ID: 32030887
[TBL] [Abstract][Full Text] [Related]
32.
Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of preoperative fluorodeoxyglucose positron emission tomography/computed tomography in patients with potentially resectable pancreatic cancer.
Omiya Y; Ichikawa S; Satoh Y; Motosugi U; Nakajima N; Onishi H
Abdom Radiol (NY); 2018 Dec; 43(12):3381-3389. PubMed ID: 30043215
[TBL] [Abstract][Full Text] [Related]
34. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
35. Canine insulinomas appear hyperintense on MRI T2-weighted images and isointense on T1-weighted images.
Walczak R; Paek M; Uzzle M; Taylor J; Specchi S
Vet Radiol Ultrasound; 2019 May; 60(3):330-337. PubMed ID: 30654407
[TBL] [Abstract][Full Text] [Related]
36. 18F-FDG PET/CT in Patients with Vulvar and Vaginal Cancer: A Preliminary Study of 20 Cases.
Gouveia P; Sá Pinto A; Violante L; Nunes S; Teixeira R; Petiz A; Duarte LH
Acta Med Port; 2022 Mar; 35(3):170-175. PubMed ID: 34818510
[TBL] [Abstract][Full Text] [Related]
37. Dual-phase computed tomographic angiography in three dogs with pancreatic insulinoma.
Mai W; Cáceres AV
Vet Radiol Ultrasound; 2008; 49(2):141-8. PubMed ID: 18418994
[TBL] [Abstract][Full Text] [Related]
38. 18-Fluoride fluorodeoxyglucose positron emission tomography is impactful in newly diagnosed pancreatic adenocarcinoma.
Power J; Larcos G
ANZ J Surg; 2023 Jan; 93(1-2):145-150. PubMed ID: 36582048
[TBL] [Abstract][Full Text] [Related]
39. (18)F-FDG-PET/CT findings in pancreatic metastasis.
Hu S; Zhang J; Zuo C; Cheng C; Liu Q; Sun G
Radiol Med; 2015 Oct; 120(10):887-98. PubMed ID: 25795439
[TBL] [Abstract][Full Text] [Related]
40. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]